Atrial and Ventricular Leadless Pacemaker Implantation Using the Internal Jugular Vein: A Multicenter Experience

Abstract Background Prior reports of internal jugular vein (IJV) access for implantation of leadless pacemakers (LLPM) are primarily small series and for ventricular LLPM. Objectives To describe outcomes of consecutive patients undergoing IJV access for both atrial and ventricular LLPM implantation. Methods This observational multicenter study included 32 consecutive patients (17 female; 69 ± 14 years; range 17–91) undergoing LLPM implantation via IJV access. Dual chamber LLPM was implanted in 16 patients, right ventricular (RV) only in 13, and right atrial (RA) only in 3. Electrical parameters were measured at implantation, 7–10 days post implantation, and at last follow‐up (mean 215 ± 98 days). Results IJV access was successful in all patients. Mean procedure and fluoroscopy times were 82 ± 40 and 16 ± 9 min, respectively. RV implant required 1.3 ± 0.6 deployments with mean of 21 min and RA implant required 1.6 ± 0.9 deployments with mean of 31 min. Electrical parameters were excellent. Current of injury for the RA LLPM is the primary indicator of engagement of the atrial myocardium. Two device‐related complications occurred without clinical sequelae; no late complications were observed. Fifteen patients were discharged the same day. Conclusions IJV access for atrial and ventricular LLPM implantation is safe and effective across a broad age range and is an alternative to FV access, enabling same‐day discharge and early ambulation. Elevated acute atrial capture thresholds with robust current of injury should not prompt repositioning, as thresholds significantly improve at early follow‐up.

Authors

Institutions

Publication Details

Journal
Pacing and Clinical Electrophysiology
Published
2026-08-18
DOI
https://doi.org/10.1111/pace.70400
Primary Topic
Cardiac pacing and defibrillation studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Atrial and Ventricular Leadless Pacemaker Implantation Using the Internal Jugular Vein: A Multicenter Experience

Mohammed Najdat Seijari, Emile G. Daoud, Taraneh Zamani, Eshaan Gandhi et al.
Pacing and Clinical Electrophysiology
Cardiac pacing and defibrillation studies
article

Atrial and Ventricular Leadless Pacemaker Implantation Using the Internal Jugular Vein: A Multicenter Experience

Mohammed Najdat Seijari, Emile G. Daoud, Taraneh Zamani, Eshaan Gandhi, Gaurang Gandhi, John J. Lee, Dilesh Patel, Daniel Cortez, Bryan Clippinger, Fawaad Athar, Muhammad Athar, Marshall Winner, Evan Schwartz, Ann Canterbury, Hemal Shah
article en

Abstract

Abstract Background Prior reports of internal jugular vein (IJV) access for implantation of leadless pacemakers (LLPM) are primarily small series and for ventricular LLPM. Objectives To describe outcomes of consecutive patients undergoing IJV access for both atrial and ventricular LLPM implantation. Methods This observational multicenter study included 32 consecutive patients (17 female; 69 ± 14 years; range 17–91) undergoing LLPM implantation via IJV access. Dual chamber LLPM was implanted in 16 patients, right ventricular (RV) only in 13, and right atrial (RA) only in 3. Electrical parameters were measured at implantation, 7–10 days post implantation, and at last follow‐up (mean 215 ± 98 days). Results IJV access was successful in all patients. Mean procedure and fluoroscopy times were 82 ± 40 and 16 ± 9 min, respectively. RV implant required 1.3 ± 0.6 deployments with mean of 21 min and RA implant required 1.6 ± 0.9 deployments with mean of 31 min. Electrical parameters were excellent. Current of injury for the RA LLPM is the primary indicator of engagement of the atrial myocardium. Two device‐related complications occurred without clinical sequelae; no late complications were observed. Fifteen patients were discharged the same day. Conclusions IJV access for atrial and ventricular LLPM implantation is safe and effective across a broad age range and is an alternative to FV access, enabling same‐day discharge and early ambulation. Elevated acute atrial capture thresholds with robust current of injury should not prompt repositioning, as thresholds significantly improve at early follow‐up.

Pacing and Clinical Electrophysiology
Bethesda North Hospital (US), Central Baptist Hospital (US), Abbott Fund (US), University of California Davis Medical Center (US)
Good health and well-being
Openalex Percentile: Top 9%
Cardiac pacing and defibrillation studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.